Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Finasteride may reduce prostate cancer risk.

Baseline PSA levels affect general health and sexual satisfaction in men with BPH treated with finasteride or placebo.

Chronic use of 1 mg/day finasteride for hair loss may delay prostate cancer diagnosis by lowering PSA levels.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

There is no link between hair loss and prostate enlargement.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Hair loss can be an early sign of prostate enlargement.

Large prostate patients more likely to have hair loss.

Researchers created five new human scalp cell lines that could be useful for hair growth and loss research.

Antigens from skin cells may cause hair loss in perinevoid alopecia.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.

Granulomatous Alopecia Areata is rare and may be caused by hair antigens or follicle destruction.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Prostate cancer screening doesn't significantly reduce death rates and has risks like overdiagnosis and side effects.

The nail immune system is similar to hair but different from skin, with fewer immune markers.

Higher PSA levels can indicate prostate cancer, but there's overlap with non-cancerous conditions.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

PSA is best for detecting prostate cancer recurrence and evaluating treatment response.

The method effectively delivers vaccines through the skin without needles.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Modified superoxide dismutase may trigger an autoimmune response in alopecia areata.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Biological therapy boosts the immune system to effectively fight melanoma.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

Anti-Desmocollin 3 antibodies can cause pemphigus-like symptoms in mice.

Anti-Desmocollin 3 antibodies can cause atypical pemphigus symptoms.